Home›Stock Screener›Abbott›Quarterly Results

Abbott Quarterly Results

Latest Quarter Net Profit
₹1,552 Cr
QMarch 2026
Quarterly Results

Abbott quarterly results. In 2026, Abbott (ABBOTINDIA) reported revenue ₹7,295 Cr and net profit ₹1,615 Cr. For annual financials, live price and key ratios, visit ABBOTINDIA share price screener.

ABBOTINDIA Quarterly Results — Revenue, Profit & EPS Highlights

Abbott latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review ABBOTINDIA PE ratio trends to evaluate earnings-based valuation against sector peers.

  • Revenue of ₹7,217 Cr in March 2026 (+0.0% vs March 2026, +8.0% vs March 2025)
  • Net Profit of ₹1,552 Cr in March 2026 (+0.0% vs March 2026, +9.8% vs March 2025)
  • EBITDA of ₹2,180 Cr in March 2026 (+0.0% vs March 2026)
  • Operating Margin of 27.0% in March 2026 (+0.0pp vs March 2026)
  • Earnings Per Share of ₹730.36 in March 2026 (+0.0% vs March 2026)

Abbott Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ABBOTINDIA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2026 March 2025 March 2024 March 2023 QoQ YoY
Revenue (₹ Cr) 7,295 7,217 6,685 6,097 5,503 1.1% -
Net Profit (₹ Cr) 1,615 1,552 1,414 1,201 949 - -
EBITDA (₹ Cr) 2,260 2,180 1,970 1,701 1,360 - -
EPS (₹) 759.80 730.36 665.62 565.28 446.80 - -
Operating Margin (%) 28.0% 27.0% 26.0% 25.0% 23.0% - -

ABBOTINDIA Share Price Trend — 1-Year Movement Across Quarterly Results

Abbott 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check Abbott market worth to track the company's total market size over time.

Profitability Ratios

Profit Margin 21.5%
EBITDA Margin 30.2%
Operating Margin 27.0%
ROE (Annual) 32.5%

Balance Sheet Highlights

Total Assets ₹6,502 Cr
Total Equity ₹4,774 Cr
Current Assets ₹3,771 Cr
Current Liabilities ₹251 Cr

Cash Flow Analysis

Operating Cash Flow ₹1,319 Cr
Investing Cash Flow ₹-371 Cr
Financing Cash Flow ₹-1,066 Cr
Net Cash Flow ₹-118 Cr

Current Market Data

Current Price ₹26000.00
Exchange NSE
Last Updated Oct 09, 2026

Revenue Trend (₹ Cr)

March 2024 6,097
March 2025 6,685
March 2026 7,217
2026 7,295

Net Profit Trend (₹ Cr)

March 2024 1,201
March 2025 1,414
March 2026 1,552
2026 1,615

Operating Margin Trend (%)

March 2024 25.0%
March 2025 26.0%
March 2026 27.0%
2026 28.0%

ABBOTINDIA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Abbott latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1760.0 15,018 2,710 -5.6% - 18.0% 155.8
Divis Laboratories
Mar 2026 		₹244,124.91 Cr 9340.0 2,986 751 -5.0% - 25.2% 329.9
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4656.9 4,111 364 +27.7% +42.2% 8.9% 404.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1117.5 7,569 1,341 -4.3% - 17.7% 88.3
Laurus Labs
Mar 2026 		₹109,629.35 Cr 2036.6 1,823 282 -10.5% - 15.5% 393.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores